BioCardia to Host Q3 2025 Corporate Update and Financial Results Conference Call on November 12, 2025

Core Insights - BioCardia, Inc. will provide a corporate update and report its financial results for the three and nine months ended September 30, 2025, on November 12, 2025, at 4:30 PM EDT [1] Company Overview - BioCardia, Inc. is a global leader in cellular and cell-derived therapeutics focused on treating cardiovascular and pulmonary diseases [4] - The company has two main biotherapeutic platforms: CardiAMP® autologous and CardiALLO™ allogeneic cell therapies, with three cardiac clinical stage product candidates currently in development [4] - BioCardia's therapies are supported by its Helix™ biotherapeutic delivery and Morph® vascular navigation product platforms [4]